Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edotecarin vs Standard Chemotherapy in Recurrent Glioblastoma
NCT00068952Phase 3Completed
- Sponsor
- Pfizer
- Start
- Aug 2003
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 3 trial of edotecarin in glioblastoma multiforme (GBM), sponsored by Pfizer. Started Aug 2003; status: completed.
02
Drugs
edotecarin
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT00068952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00068952.